12/2
04:45 pm
cah
Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Cardinal Health, Inc. (CAH) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/2
12:27 pm
cah
Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve [Yahoo! Finance]
Low
Report
Zacks.com featured highlights include Life Time, Cardinal Health, LeMaitre Vascular and Flowserve [Yahoo! Finance]
12/1
02:27 pm
cah
Citius Oncology rises after U.S. launch of Lymphir as a cancer treatment [Seeking Alpha]
Low
Report
Citius Oncology rises after U.S. launch of Lymphir as a cancer treatment [Seeking Alpha]
11/25
11:18 am
cah
Top Healthcare revenue stocks as hedge funds sell Tech stocks to buy the sector [Seeking Alpha]
Low
Report
Top Healthcare revenue stocks as hedge funds sell Tech stocks to buy the sector [Seeking Alpha]
11/20
07:04 pm
cah
Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy? [Yahoo! Finance]
Low
Report
Cardinal Health (CAH) is a Top-Ranked Growth Stock: Should You Buy? [Yahoo! Finance]
11/19
09:33 am
cah
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $195.00 to $208.00. They now have a "hold" rating on the stock.
Low
Report
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $195.00 to $208.00. They now have a "hold" rating on the stock.
11/19
04:27 am
cah
Stop Sleeping on These 3 Stocks (Seriously) [Yahoo! Finance]
Low
Report
Stop Sleeping on These 3 Stocks (Seriously) [Yahoo! Finance]
11/17
09:33 am
cah
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Leerink Partners from $211.00 to $230.00. They now have an "outperform" rating on the stock.
Low
Report
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Leerink Partners from $211.00 to $230.00. They now have an "outperform" rating on the stock.
11/12
02:45 pm
cah
OnPoint Surgical, Inc. Appoints Jeremy Laynor as Chief Commercial Officer to Accelerate Global Growth [Yahoo! Finance]
Low
Report
OnPoint Surgical, Inc. Appoints Jeremy Laynor as Chief Commercial Officer to Accelerate Global Growth [Yahoo! Finance]
11/11
11:43 am
cah
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
Low
Report
Cardinal Health, Inc. (CAH) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]
11/8
07:05 pm
cah
Cardinal Health (CAH): A Closer Look at Valuation Following Robust Share Price Gains [Yahoo! Finance]
Low
Report
Cardinal Health (CAH): A Closer Look at Valuation Following Robust Share Price Gains [Yahoo! Finance]
11/8
09:39 am
cah
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Argus from $189.00 to $211.00. They now have a "buy" rating on the stock.
Low
Report
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Argus from $189.00 to $211.00. They now have a "buy" rating on the stock.
11/7
07:07 pm
cah
Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic? [Yahoo! Finance]
Low
Report
Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic? [Yahoo! Finance]
11/6
05:20 pm
cah
Best Vascular/Novoste Marks 25 Years Since FDA Approval of Vascular Brachytherapy [Yahoo! Finance]
Medium
Report
Best Vascular/Novoste Marks 25 Years Since FDA Approval of Vascular Brachytherapy [Yahoo! Finance]
11/6
05:00 am
cah
Cardinal Health Stock: Analyst Estimates & Ratings [Yahoo! Finance]
Low
Report
Cardinal Health Stock: Analyst Estimates & Ratings [Yahoo! Finance]
11/6
02:51 am
cah
The 5 Most Interesting Analyst Questions From Cardinal Health's Q3 Earnings Call [Yahoo! Finance]
Low
Report
The 5 Most Interesting Analyst Questions From Cardinal Health's Q3 Earnings Call [Yahoo! Finance]
11/5
10:06 am
cah
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Wells Fargo & Company from $185.00 to $221.00. They now have an "overweight" rating on the stock.
Low
Report
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Wells Fargo & Company from $185.00 to $221.00. They now have an "overweight" rating on the stock.
11/4
04:45 pm
cah
Cardinal Health Board of Directors Approves Quarterly Dividend
Low
Report
Cardinal Health Board of Directors Approves Quarterly Dividend
11/3
08:01 pm
cah
Cardinal Health (NYSE:CAH) was given a new $210.00 price target on by analysts at Mizuho.
Low
Report
Cardinal Health (NYSE:CAH) was given a new $210.00 price target on by analysts at Mizuho.
11/3
06:10 pm
cah
Cardinal Health (NYSE:CAH) was given a new $220.00 price target on by analysts at Jefferies Financial Group Inc..
Low
Report
Cardinal Health (NYSE:CAH) was given a new $220.00 price target on by analysts at Jefferies Financial Group Inc..
11/3
11:49 am
cah
Cardinal Health (NYSE:CAH) had its price target raised by analysts at TD Cowen from $183.00 to $225.00. They now have a "buy" rating on the stock.
Low
Report
Cardinal Health (NYSE:CAH) had its price target raised by analysts at TD Cowen from $183.00 to $225.00. They now have a "buy" rating on the stock.
11/3
08:30 am
cah
Cardinal Health completes acquisition of Solaris Health
Low
Report
Cardinal Health completes acquisition of Solaris Health
11/1
09:38 am
cah
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Leerink Partners from $187.00 to $211.00.
Low
Report
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Leerink Partners from $187.00 to $211.00.
10/31
07:06 pm
cah
Cardinal Health Stock Is on Pace for Its Highest Close on Record. Here's Why. [Yahoo! Finance]
Low
Report
Cardinal Health Stock Is on Pace for Its Highest Close on Record. Here's Why. [Yahoo! Finance]
10/31
04:42 pm
cah
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Citigroup Inc. from $165.00 to $190.00. They now have a "neutral" rating on the stock.
Low
Report
Cardinal Health (NYSE:CAH) had its price target raised by analysts at Citigroup Inc. from $165.00 to $190.00. They now have a "neutral" rating on the stock.